REVB - Total Utang marang Modal Revelation Biosciences Corp

Logo perusahaan publik Revelation Biosciences (REVB)

The price history of Revelation Biosciences (REVB) demonstrates a total debt-to-equity ratio of 0.07. Revelation Biosciences is optimizing the delivery of immunological agents through a network of specialized temperature-controlled hubs to protect profits. The firm's financial position depends on the outcomes of clinical trials for modulating drugs. Meanwhile, FDA Fast Track status is accelerating the market launch of immune stimulation systems for surgery.

REVB: Total Utang marang Modal Revelation Biosciences, Inc. 04.07.2022 - 30.10.2026

Rincian analitis perusahaan Revelation Biosciences

- rega lan prakiraan konsensus rega:
Bagan rega Revelation Biosciences, Inc.|REVB - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar Revelation Biosciences|REVB - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham Revelation Biosciences|REVB - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku revbiosciences.com|REVB - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Revelation Biosciences|REVB - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Revelation Biosciences|REVB - Gunggung utang perusahaan|Utang marang nilai buku Revelation Biosciences|REVB - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Revelation Biosciences|Likuiditas cepet revbiosciences.com
- informasi bathi lan kelipatan valuasi:
REVB - Penghasilan resik
Analisis dhasar perusahaan:Revelation Biosciences, Inc.
Barang utama Revelation Biosciences Corp

Revelation Biosciences is developing a unique immunotherapy ecosystem based on the Gemini platform, creating a closed loop of proprietary molecules. An analysis of the debt-to-equity ratio allows for an assessment of this R&D-intensive business's degree of dependence on creditors relative to its shareholder equity. The dynamics of this leverage determine the company's financial stability, helping investors distinguish strategic development from systemic capital degradation.

Analisis pesaing Revelation Biosciences

Utang marang Ekuitas argenx|BioNTech Inc. - Utang Agregat marang Ekuitas|Total Utang marang Modal ABVX|ADMA (ADMA Corp) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PTGX (Protagonist Therapeutics)|Total Utang marang Modal immunovant.com IMVT|KNSA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi GRFS (Grifols SA)|Adaptive Biotechnologies Corp (ADPT) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Celldex Corp|AUPH (Aurinia Pharmaceuticals) - Total Utang marang Modal|Total Utang marang Modal biocryst.com|Rasio Total Utang marang Ekuitas VERA (Vera Therapeutics)|DNTH (Dianthus Therapeutics Inc) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal PHVS (Pharvaris Corp)|Koefisien Total Utang marang Modal AbCellera (ABCL)|TRML - Utang marang Ekuitas|precigen.com (PGEN) - Rasio Total Utang marang Ekuitas|Pharming Group (PHAR) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Nektar Therapeutics Inc|Rasio Total Utang marang Ekuitas UPB|Total Utang marang Modal Zenas Corp|Utang marang Ekuitas Immunome, Inc. (IMNM)|gossamerbio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal KALV (KalVista Pharmaceuticals, Inc.)|Septerna, Inc. (SEPN) - Utang marang Modal|PVLA - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SVRA (Savara Pharma)|RIGL: Total Utang marang Modal|Utang marang Modal anaptysbio.com (ANAB)|Rasio Total Utang marang Ekuitas ATXS|Utang marang Ekuitas ENGN|Total Utang marang Modal RAPT|JBIO - Utang marang Modal|Utang marang Ekuitas Aclaris Therapeutics ACRS|kyvernatx.com - Utang marang Ekuitas|Tiziana Life Sciences Ltd - Total Utang marang Modal|CABA - Total Utang marang Modal|VTYX (Ventyx Bio) - Rasio Total Utang marang Ekuitas|THTX: Utang Agregat marang Modal|AVTX (Avalo Therapeutics, Inc) - Total Utang marang Modal|eledon.com (ELDN) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Agenus Inc. (AGEN)|CLYM - Utang marang Modal|Utang marang Ekuitas Zura Bio Limited ZURA|ATYR: Rasio Utang marang Ekuitas|ADAG: Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi IMA (ImageneBio Inc)|STTK: Total Utang marang Modal|EQ (Equillium) - Utang marang Ekuitas|CNTB (Connect Biopharma Holdings) - Total Utang marang Modal|Immunic Inc (IMUX) - Koefisien Total Utang marang Modal|Utang marang Ekuitas Atara Biotherapeutics (ATRA)|IFRX - Utang marang Modal|Utang marang Ekuitas X4 Pharmaceuticals, Inc. XFOR|Koefisien Total Utang marang Modal Adicet Bio Inc. (ACET)|Celularity Corp - Total Utang marang Modal|INmune Bio Corporation (INMB) - Rasio Total Utang marang Ekuitas|BRNS: Total Utang marang Modal|KZR - Koefisien Total Utang marang Modal|SABS (SAB Biotherapeutics, Inc.) - Total Utang marang Modal|Utang marang Modal Akari Therapeutics PLC AKTX|Utang marang Ekuitas Enlivex Therapeutics (ENLV)|q32bio.com - Rasio Utang marang Ekuitas|Total Utang marang Modal GOVX (GeoVax Labs, Inc.)|EDSA - Rasio Total Utang marang Ekuitas|iBio - Total Utang marang Modal|Utang marang Modal Carisma Therapeutics|XTL Biopharmaceuticals, Ltd. (XTLB) - Utang marang Ekuitas|BOLT - Koefisien Total Utang marang Modal|Utang marang Ekuitas HCW Biologics, Inc.|APVO: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal AIM|ADTX - Utang marang Modal|GRI Bio Corp - Rasio Total Utang marang Ekuitas|XORTX Corp - Utang marang Ekuitas|Vyome Holdings Inc - Total Utang marang Modal|INDP: Utang marang Ekuitas|Scinai Immunotherapeutics Ltd. (SCNI) - Utang marang Ekuitas|Utang Agregat marang Ekuitas CALI (CalciMedica)|AFMD (Affimed NV) - Total Utang marang Modal|ALLK: Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal HOOK|Total Utang marang Modal igmbio.com (IGMS)|Utang marang Ekuitas iTeos Therapeutics, Inc. ITOS|Rasio Kabeh Utang marang Dana Pribadi OCEA|TCBP - Utang marang Ekuitas|Third Harmonic Bio Inc (THRD) - Rasio Total Utang marang Ekuitas